Not yet recruiting
Peripheral venous disease
Not yet recruitingEfficacy and Safety of Heparan Sulphate 120 mg Prolonged‑Release Tablets in Patients with Primary Chronic Venous Disease of the Lower Limbs
Investigational
Efficacy and Safety of Heparan Sulphate 120 mg Prolonged‑Release Tablets in Patients with Primary Chronic Venous Disease of the Lower Limbs
Investigational
- Disease:Peripheral venous disease
- Substances:–
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Sponsor:Farmaceutici Damor S.p.A.